ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
April 2026
Nuclear Technology
February 2026
Fusion Science and Technology
Latest News
Swiss nuclear power and the case for long-term operation
Designed for 40 years but built to last far longer, Switzerland’s nuclear power plants have all entered long-term operation. Yet age alone says little about safety or performance. Through continuous upgrades, strict regulatory oversight, and extensive aging management, the country’s reactors are being prepared for decades of continued operation, in line with international practice.
D. Lynn Shaeffer, F. Owen Hoffman
Nuclear Technology | Volume 45 | Number 1 | August 1979 | Pages 99-106
Technical Paper | Radioactive Waste | doi.org/10.13182/NT79-A32288
Articles are hosted by Taylor and Francis Online.
An analysis was made of the uncertainty in the prediction of dose to an individual’s thyroid due to the transport of radioactive molecular iodine, 131I2, from air through the pasture-cow-milk pathway. This analysis was facilitated by the adoption of a model consisting of a multiplication of several factors represented by lognormal distributions of values. Results indicate there is a 64, 50, or 23% chance of the annual dose to an individual’s thyroid not exceeding the mean, median, or most probable doses, respectively. However, these results are tentative as a result of the limited amount of data available for annual average dose assessments. The suggestion is made that consideration be given to adopting a probabilistic approach to determining an acceptable probability of an individual receiving a dose that exceeds a limiting value.